Where to find our staff next week
At ACR 2017, you’ll find Cleveland Clinic physicians and fellows from the Department of Rheumatic and Immunologic Diseases everywhere from oral sessions to workshops and ‘Meet the Professor’ activities. Don’t miss these nine scientific and poster presentations on topics from PACNS to checkpoint therapy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Tuesday, Nov. 7
Controversies with Vitamin D Use for Bone Health
Chad Deal, MD: Speaker/Facilitator
7:45-9:15 a.m.
Wednesday, Nov. 8
Empathy: Why Should I Care?
Leonard Calabrese, DO: Speaker/Facilitator
11-11:30 a.m.
Sunday, Nov. 5
What Is the Impact of Functional Medicine on Patient Reported Outcomes in Inflammatory Arthritis?
Session title: Patient Outcomes, Preferences, and Attitudes Poster II
9-11 a.m.
Monday, Nov. 6
Rheumatic Immune Related Adverse Events from Checkpoint Inhibitor Therapy for Cancer: Long-Term Follow up Data
Session title: Miscellaneous Rheumatic and Inflammatory Diseases Poster I
9-11 a.m.
Increase in Arginase Activity and Related Arginine Metabolites in Patients with Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA): Potential Mechanisms for Endothelial Dysfunction
Session title: Spondyloarthropathies Psoriatic Arthritis – Pathogenesis, Etiology Poster II
9-11 a.m.
Tuesday, Nov. 7
Immunotherapy-Induced Rheumatic Disease: How Prepared Are Rheumatologists
Session title: Rheumatoid Arthritis – Clinical Aspects Poster III: Comorbidities
9-11 a.m.
Differentiating Features of Primary Angiitis of Central Nervous System and Reversible Cerebral Vasoconstriction Syndrome: Clinical and Radiological Evaluation
Session title: Vasculitis Poster III: Other Vasculitis Syndromes
9-11 a.m.
The Utility of Unbiased Metagenomic Next Generation Sequencing in the Management of Patients with CNS Vasculitis
Session title: Vasculitis Poster III: Other Vasculitis Syndromes
9-11 a.m.
Rapid Tophus Resolution in Chronic Refractory Gout Patients Treated with Pegloticase
Session title: Metabolic and Crystal Arthropathies Poster II
9-11 a.m.
E-coaching program is tailored for those with the disease
Sustained efficacy and safety
New long-term outcomes data offer insights
Evaluating PROs in immune-mediated diseases
A practical PRO biomarker databank
Distinguishing the cause of fevers in patients with lupus
Relationship in patients treated with pegloticase
Response to vaccine in inadequate responders to methotrexate